Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNB4 | O00305 | 4/20 | 0.43 |
| ▸ | CACNA1A | O00555 | 4/20 | 0.43 |
| ▸ | CACNA1G | O43497 | 4/20 | 0.43 |
| ▸ | CACNG3 | O60359 | 4/20 | 0.43 |
| ▸ | CACNA1F | O60840 | 4/20 | 0.43 |
| ▸ | CACNA1H | O95180 | 4/20 | 0.43 |
| ▸ | CACNB3 | P54284 | 4/20 | 0.43 |
| ▸ | CACNA2D1 | P54289 | 4/20 | 0.43 |
| ▸ | CACNG7 | P62955 | 4/20 | 0.43 |
| ▸ | CACNA1B | Q00975 | 4/20 | 0.43 |
| ▸ | CACNA1D | Q01668 | 4/20 | 0.43 |
| ▸ | CACNB1 | Q02641 | 4/20 | 0.43 |
| ▸ | CACNG1 | Q06432 | 4/20 | 0.43 |
| ▸ | CACNB2 | Q08289 | 4/20 | 0.43 |
| ▸ | CACNA1S | Q13698 | 4/20 | 0.43 |
| ▸ | CACNA1C | Q13936 | 4/20 | 0.43 |
| ▸ | CACNA1E | Q15878 | 4/20 | 0.43 |
| ▸ | CACNA2D4 | Q7Z3S7 | 4/20 | 0.43 |
| ▸ | CACNA2D3 | Q8IZS8 | 4/20 | 0.43 |
| ▸ | CACNG8 | Q8WXS5 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24939886 | 0.89 | HTR6 (0.45) | CACNB4CACNA1ACACNA1GCACNG3CACNA1F | |
| SCHEMBL24939868 | 0.87 | HTR6 (0.53) | CACNB4CACNA1ACACNA1GCACNG3CACNA1F | |
| SCHEMBL24939945 | 0.86 | PPARD (0.46) | CACNB4CACNA1ACACNA1GCACNG3CACNA1F | |
| SCHEMBL24939885 | 0.84 | CACNB4 (0.44) | CACNB4CACNA1ACACNA1GCACNG3CACNA1F | |
| SCHEMBL24939995 | 0.84 | HDAC3 (0.42) | CACNB4CACNA1ACACNA1GCACNG3CACNA1F | |
| SCHEMBL24939957 | 0.80 | F10 (0.41) | HTR6HDAC3HDAC1HDAC2HDAC10 | |
| SCHEMBL24152329 | 0.79 | GSK3B (0.50) | SIGMAR1GSK3AGSK3B | |
| SCHEMBL24939910 | 0.77 | HTR6 (0.41) | HTR6HDAC1HDAC8HDAC6 | |
| SCHEMBL24939879 | 0.75 | PDE4A (0.42) | HTR6HDAC3HDAC1HDAC2HDAC10 | |
| SCHEMBL30336993 | 0.74 | TP53 (0.45) | CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230019094-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER COMPRISING SAME | HOLOSMEDIC (KR) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230019094-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER COMPRISING SAME | TP53, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, ABCC1 | CACNB4 2703/4885CACNA1A 2603/4885CACNA1G 3134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.